Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Chimeric antigen receptor (CAR) T-cell therapy: Engineering immune cells to treat liver diseases

Journal of Hepatology(2025)10.1016/j.jhep.2025.06.007Source: DataRank Database

Chimeric antigen receptor (CAR) T-cell therapy: Engineering immune cells to treat liver diseases is a research paper published in Journal of Hepatology (2025). On theSindex it has a DataRank of 0. It has been cited 21 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access21 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 10.07)OA: hybridTopics (47)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Scott L. Friedman ORCID,Michael Hudecek ORCID,Ulrike Protzer ORCID,Elmar Jaeckel ORCID

Live enrichment

PubMed:40545042 OpenAlex:https://openalex.org/W4411466085

Deutsche Forschungsgemeinschaft

Grant: SFB-TRR 338

Deutsche Forschungsgemeinschaft

Grant: 452881907

National Institutes of Health

Grant: 2R01DK128289

Deutsche Forschungsgemeinschaft

Grant: unidentified

unidentified

Icahn School of Medicine at Mount Sinai

Bavarian Research Foundation

FWCI

10.07

Citation Percentile

1.0%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1016/j.jhep.2025.06.007

publisherhttps://doi.org/10.1016/j.jhep.2025.06.007

publisherhttps://api.elsevier.com/content/article/PII:S0168827825022743?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0168827825022743?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40545042

Fields of Study

CAR-T cell therapy researchBiomedical and Engineering EducationBiomedical Ethics and Regulation03 medical and health sciences0302 clinical medicineHumansReceptors, Chimeric AntigenLiver DiseasesImmunotherapy, AdoptiveT-LymphocytesCell Engineering

MeSH Terms

Receptors, Chimeric AntigenHumansLiver DiseasesT-LymphocytesImmunotherapy, AdoptiveCell Engineering

Keywords

Chimeric antigen receptorImmune systemAntigenCell therapyImmunologyReceptorMedicineT cellCancer researchCellBiologyInternal medicineBiochemistryHepatitis BHepatocellular carcinomaLiver cancerLiver fibrosisLiver transplantationHCCCHBregulatory T cellTregAutoimmune Liver DiseaseCar T CellsReceptors, Chimeric AntigenLiver DiseasesT-LymphocytesHumansImmunotherapy, AdoptiveCell Engineering

Sustainable Development Goals

SDG 0: Good health and well-being